INDRAMEDCO vs MEDANTA: Stock Comparison
GLOBAL HEALTH is the larger company by market capitalisation. INDRAPRASTHA MEDICAL CORP shows a lower P/E, a higher ROE and a higher dividend yield, while GLOBAL HEALTH shows faster revenue growth and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
INDRAMEDCO leads 8; MEDANTA leads 5 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | INDRAMEDCO | MEDANTA |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Hospital | Hospital |
Price
| Metric | INDRAMEDCO | MEDANTA |
|---|---|---|
| Live Price | ₹355 | ₹1,447.2 |
| Day Change | -1.39% | -0.85% |
| Volume | 1.85 L | 74,678 |
| 52-Week High | ₹640.85 | ₹1,544 |
| 52-Week Low | ₹342 | ₹956 |
| Distance from 52W High | -44.6% | -6.27% |
Valuation
| Metric | INDRAMEDCO | MEDANTA |
|---|---|---|
| Market Cap | ₹3,246 Cr | ₹38,774 Cr |
| P/E Ratio | 17.26x | 69.7x |
| P/B Ratio | 4.38x | 9.78x |
| EPS | ₹6.09 | ₹5.9 |
| Book Value | ₹80.76 | ₹148.18 |
| Dividend Yield | 1.27% | 0.03% |
Growth
| Metric | INDRAMEDCO | MEDANTA |
|---|---|---|
| Revenue Growth (TTM YoY) | 9.3% | 24.5% |
| EPS Growth (TTM YoY) | 1.8% | 42% |
| Qtr Sales Growth | 11.33% | 20.89% |
| Qtr Profit Growth | 33.93% | 14.53% |
Profitability & Leverage
| Metric | INDRAMEDCO | MEDANTA |
|---|---|---|
| ROE | 24.8% | 12.37% |
| ROCE | 25.98% | 11.4% |
| Net Margin | 12.21% | 12.62% |
| Operating Margin | 17% | 18.62% |
| Debt to Equity | 0x | 0.17x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | INDRAMEDCO | MEDANTA |
|---|---|---|
| Promoter Holding | 49.39% | 33%▼ 0.01 pp |
| FII Holding | 2.77%▲ 0.33 pp | 9.46%▼ 0.69 pp |
| DII Holding | 0.59%▼ 0.29 pp | 16.89%▲ 2.13 pp |
| Public Holding | 45.64%▼ 0.05 pp | 40.56%▼ 1.44 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: INDRAPRASTHA MEDICAL CORP and GLOBAL HEALTH.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.